Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty

PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Precocious Puberty
Interventions
DRUG

Triptorelin pamoate 11.25mg (Decapeptyl® SR)

One intra muscular injection at day 1 and month 3.

Trial Locations (18)

13385

Hôpital de la Timone Enfants, Marseille

21034

Hôpital du Bocage, Dijon

25030

Hôpital Saint-Jacques, Besançon

31026

Hôpital des Enfants, Toulouse

33000

Medical Centre, Bordeaux

49033

Hôpital Hotel-Dieu (CHU), Angers

51092

American Memorial Hospital, Reims

59037

Hôpital Jeanne de Flandre, Lille

65013

Hôpital de la Gespe, Tarbes

67100

Hôpital Hautepierre, Strasbourg

69322

Hôpital Debrousse, Lyon

75012

Hôpital Trousseau, Paris

75014

Hôpital St-Vincent de Paul, Paris

75015

Hôpital Necker - Enfants Malades, Paris

75019

Hôpital Robert Debré, Paris

76031

Hôpital Charles Nicolle, Rouen

76083

Hôpital Flaubert, Le Havre

06202

Hôpital Archet 2, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY